Results 191 to 200 of about 9,672 (236)

Adrenal Metastasis of Hepatocellular Carcinoma With Unknown Primary: A Case Report. [PDF]

Cureus
Conger C, Yassa J, Agarwal M, Arora S, Newman N.   +4 more
europepmc   +1 more source

FDA-approved antivirals ledipasvir and daclatasvir downregulate the Src-EPHA2-Akt oncogenic pathway in colorectal and triple-negative breast cancer cells

Betlem Mezquita, Marjorie Reyes‐Farias, Miquel Pons   +2 more
openalex   +1 more source

Autoimmune Hepatitis After Successful Treatment of Chronic Hepatitis C Virus Infection with Direct-Acting Antivirals: A Pediatric Case Report. [PDF]

Pathogens
Talarek E, Aniszewska M, Dobrzeniecka A, Kmiotek J, Pokorska-Śpiewak M.   +4 more
europepmc   +1 more source

HCV Reactivation Risk in Patients Undergoing Treatment for Inflammatory Arthritis and Connective Tissue Diseases. [PDF]

Mediterr J Rheumatol
Pappa M, Androutsakos T, Karamanakos A, Mole E, Gazi S, Atzeni F, Sebastiani M, Vassilakis KD, Papagoras C, Kougkas N, Fragoulis GE.   +10 more
europepmc   +1 more source

Hepatitis C Direct-Acting Antivirals in the Immunosuppressed Host: Mechanisms, Interactions, and Clinical Outcomes. [PDF]

Viruses
AlKaabi H, AlSinani S, El-Kassas M, Alswat KA, AlNaamani KM.   +4 more
europepmc   +1 more source

A Bibliometric Analysis of the HCV Drug-Resistant Majority and Minority Variants. [PDF]

Int J Environ Res Public Health
Immanuel OM, Fabiyi OT, Oshakbayev KP, Abuova G, Konysbekova A, Vattipally SB, Ali S, Abidi SH.   +7 more
europepmc   +1 more source

Micro-elimination of Hepatitis C virus (HCV) infection in the General Population Cohort in rural Uganda: long-term follow-up to assess feasibility and outcomes of a screening and treatment intervention

Mugisha J, Kimono B, Lumley S, O’Hara G, Waddilove E, Wekesa C, Mgomella G, Makanga R, Ndungutse R, Nyirenda M, Davis C, Thomson E, Ocama P, Seeley J, Matthews PC, Newton R.   +15 more
europepmc   +1 more source

Pharmaceutical industry payments and prescriptions of direct acting antiviral drugs for hepatitis C virus infection. [PDF]

Liver Int
Murayama A, Sigel KM, Tarras ES, Marshall DC.   +3 more
europepmc   +1 more source

Baseline features of patients according to the presence of HBV reactivation. HBV, hepatitis B virus; HCV, hepatitis C virus; HCC, hepatocellular carcinoma; DAA, direct acting antiviral agents; DCV, daclatasvir; ASV, asunaprevir; SOF, sofosbuvir; RBV, ribavirin; OPr-D, ombitavir/paritaprevir/ritonavir plus dasabuvir; G/P, glecaprevir/pibrentasvir; LDV, ledipasvir; SVR, sustained virological response; IFN, interferon; DAA, direct acting antiviral.

Young Joo Park (8911286), Ki Youn Yi (21453236), Hyun Young Woo (4568179), Jeong Heo (388115), Geun Am Song (4568182)   +4 more
openalex   +1 more source